These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15545669)

  • 1. Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer.
    Pierce LJ; Hutchins LF; Green SR; Lew DL; Gralow JR; Livingston RB; Osborne CK; Albain KS
    J Clin Oncol; 2005 Jan; 23(1):24-9. PubMed ID: 15545669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102.
    Hutchins LF; Green SJ; Ravdin PM; Lew D; Martino S; Abeloff M; Lyss AP; Allred C; Rivkin SE; Osborne CK
    J Clin Oncol; 2005 Nov; 23(33):8313-21. PubMed ID: 16293862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse rates.
    Ahn PH; Vu HT; Lannin D; Obedian E; DiGiovanna MP; Burtness B; Haffty BG
    J Clin Oncol; 2005 Jan; 23(1):17-23. PubMed ID: 15545666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment.
    Harris EE; Christensen VJ; Hwang WT; Fox K; Solin LJ
    J Clin Oncol; 2005 Jan; 23(1):11-6. PubMed ID: 15545665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial.
    Toledano A; Azria D; Garaud P; Fourquet A; Serin D; Bosset JF; Miny-Buffet J; Favre A; Le Floch O; Calais G
    J Clin Oncol; 2007 Feb; 25(4):405-10. PubMed ID: 17264336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sequential study of radiotherapy and hormonal therapy in breast cancer patients undergoing mastectomy or conservative surgery].
    Wang XC; Huang XB; Zhang WD; Liu MZ; Guang XX; Liu XQ
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1964-9. PubMed ID: 19950570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen.
    Isaac N; Panzarella T; Lau A; Mayers C; Kirkbride P; Tannock IF; Vallis KA
    Cancer; 2002 Aug; 95(4):696-703. PubMed ID: 12209711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.
    Kaufmann M; Graf E; Jonat W; Eiermann W; Geberth M; Albert US; Gademann G; Conrad B; Stahl K; von Minckwitz G; Schumacher M;
    J Clin Oncol; 2005 Nov; 23(31):7842-8. PubMed ID: 16258087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New methods in the treatment of breast cancer].
    Semiglazov VF
    Vopr Onkol; 1997; 43(1):22-6. PubMed ID: 9133082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.
    Fisher B; Jeong JH; Anderson S; Wolmark N
    J Natl Cancer Inst; 2004 Dec; 96(24):1823-31. PubMed ID: 15601638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.
    Benchalal M; Le Prisé E; de Lafontan B; Berton-Rigaud D; Belkacemi Y; Romestaing P; Peignaux K; Courdi A; Monnier A; Montcuquet P; Goudier MJ; Marchal C; Chollet P; Abadie-Lacourtoisie S; Datchary J; Veyret C; Kerbrat P
    Cancer; 2005 Jul; 104(2):240-50. PubMed ID: 15948160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.
    ; Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
    J Clin Oncol; 2006 May; 24(15):2268-75. PubMed ID: 16618947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial.
    Fargeot P; Bonneterre J; Roché H; Lortholary A; Campone M; Van Praagh I; Monnier A; Namer M; Schraub S; Barats JC; Guastalla JP; Goudier MJ; Chapelle-Marcillac I
    J Clin Oncol; 2004 Dec; 22(23):4622-30. PubMed ID: 15505276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group B 9344.
    Sartor CI; Peterson BL; Woolf S; Fitzgerald TJ; Laurie F; Turrisi AJ; Bogart J; Henderson IC; Norton L
    J Clin Oncol; 2005 Jan; 23(1):30-40. PubMed ID: 15545661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials.
    Noguchi S; Koyama H; Uchino J; Abe R; Miura S; Sugimachi K; Akazawa K; Abe O
    J Clin Oncol; 2005 Apr; 23(10):2172-84. PubMed ID: 15800310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of radiation boost after whole-breast radiotherapy.
    Livi L; Borghesi S; Saieva C; Fambrini M; Iannalfi A; Greto D; Paiar F; Scoccianti S; Simontacchi G; Bianchi S; Cataliotti L; Biti G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1029-34. PubMed ID: 19395193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer.
    Gordon NH; Silverman P; Lasheen W; Meinert J; Siminoff LA
    Breast Cancer Res Treat; 2007 May; 102(3):301-12. PubMed ID: 17033926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of concurrent adjuvant chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer.
    Han S; Kim J; Sohn S; Kwak GH; Kim JY; Park K
    J Surg Oncol; 2007 Jan; 95(1):45-50. PubMed ID: 17192866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma.
    Livi L; Saieva C; Borghesi S; Paoletti L; Meattini I; Rampini A; Petrucci A; Scoccianti S; Paiar F; Cataliotti L; Leonulli BG; Bianchi S; Biti GP
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):705-9. PubMed ID: 18191333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.